This paper describes the development of a novel rabies virus vaccine candidate using a self-assembling nanoparticle engineered from the ferritinophagy complex. The engineered ferritinophagy (Fagy)-tag peptide shows enhanced binding to the ferritin nanoparticle, facilitating efficient antigen presentation. A self-assembling vaccine, conjugating Fagy-tagged rabies virus glycoprotein domain III (GDIII) to the nanoparticle, exhibits superior homogeneity, stability, and immunogenicity. The vaccine induces potent and durable immune responses, protecting mice against rabies virus challenge after a single dose. This platform holds potential for developing vaccines against various pathogens.
Publisher
Nature Communications
Published On
Oct 04, 2024
Authors
Dan Fu, Wenming Wang, Yan Zhang, Fan Zhang, Pinyi Yang, Chun Yang, Yufei Tian, Renqi Yao, Jingwu Jian, Zixian Sun, Nan Zhang, Zhiyu Ni, Zihe Rao, Lei Zhao, Yu Guo
Tags
rabies virus
vaccine candidate
self-assembling nanoparticle
immunogenicity
ferritinophagy
antigen presentation
immune response
Related Publications
Explore these studies to deepen your understanding of the subject.